Pablo Hernández-Alonso

Dr. Pablo Hernández-Alonso

Human Nutrition Unit, Faculty of Medicine and Health Sciences, Institut d'Investigació Sanitària Pere Virgili, University Hospital Sant Joan de Reus, Rovira i Virgili University, Reus, Spain
+2
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
NRNuria Rosique-Esteban
Nuria Rosique-Esteban
MGMarta Guasch-Ferré
Marta Guasch-Ferré
Pablo Hernández-AlonsoPablo Hernández-Alonso
Pablo Hernández-Alonso
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
Magnesium (Mg) is an essential dietary element for humans involved in key biological processes. A growing body of evidence from epidemiological studies, randomized controlled trials (RCTs) and meta-analyses have indicated inverse associations between Mg intake and cardiovascular diseases (CVD). The present review aims to summarize recent scientific evidence on the topic, with a focus on data from epidemiological studies assessing the associations between Mg intake and major cardiovascular (CV) risk factors and CVD. We also aimed to review current literature on circulating Mg and CVD, as well as potential biological processes underlying these observations. We concluded that high Mg intake is associated with lower risk of major CV risk factors (mainly metabolic syndrome, diabetes and hypertension), stroke and total CVD. Higher levels of circulating Mg are associated with lower risk of CVD, mainly ischemic heart disease and coronary heart disease. Further, RCTs and prospective studies would help to clarify whether Mg intake and Mg circulating levels may also protect against other CVDs and CVD death.

1 July 2014 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
MJMartí Juanola-Falgarona
Martí Juanola-Falgarona
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
NINúria Ibarrola-Jurado
Núria Ibarrola-Jurado
ARAntoni Rabassa-Soler
Antoni Rabassa-Soler
ADAndrés Díaz-López
Andrés Díaz-López
MBMonica Bullo
Monica Bullo
Background: Low–glycemic index (GI) diets have been proven to have beneficial effects in such chronic conditions as type 2 diabetes, ischemic heart di

1 April 2015 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MBMonica Bullo
Monica Bullo
MJM. Juanola-Falgarona
M. Juanola-Falgarona
Pablo Hernández-AlonsoPablo Hernández-Alonso
Pablo Hernández-Alonso
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
Epidemiological and/or clinical trials have suggested that nut consumption has a beneficial impact on health outcomes such as hypertension, diabetes, CVD, cancer, other inflammatory conditions and total mortality. Nuts are nutrient-dense foods with a healthy fatty acid profile, as well as provide other bioactive compounds with recognised health benefits. Among nuts, pistachios have a lower fat and energy content and the highest levels of K, γ-tocopherol, vitamin K, phytosterols, xanthophyll carotenoids, certain minerals (Cu, Fe and Mg), vitamin B6and thiamin. Pistachios have a high antioxidant and anti-inflammatory potential. The aforementioned characteristics and nutrient mix probably contribute to the growing body of evidence that consumption of pistachios improves health. The present review examines the potential health effects of nutrients and phytochemicals in pistachios, as well as epidemiological and clinical evidence supporting these health benefits.

30 July 2020 in Advances in Nutrition
Verified
Journal Article
Closed access
PDF file
SCSilvia Canudas
Silvia Canudas
NBNerea Becerra-Tomás
Nerea Becerra-Tomás
Pablo Hernández-AlonsoPablo Hernández-Alonso
Pablo Hernández-Alonso
SGSerena Galié
Serena Galié
CLCindy Leung
Cindy Leung
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
Accelerated telomere shortening has been associated with several age-related diseases and/or decreased lifespan in humans. The Mediterranean diet (MedDiet) is considered to be 1 of the most recognized diets for disease prevention and healthy aging, partially due to its demonstrated anti-inflammatory and antioxidative properties which may impact on telomere length (TL). The aim of this meta-analysis was to determine the associations between MedDiet adherence and TL maintenance. MEDLINE-PubMed and Cochrane databases were searched up to December 2018 for studies evaluating the association between MedDiet adherence and TL in blood cells. Two reviewers, working independently, screened all titles and abstracts to identify studies that met the inclusion criteria [cross-sectional, case-control, and prospective cohort studies and randomized clinical trials (RCTs) published in English and excluded nonoriginal articles]. Data were pooled by the generic inverse variance method using the random effects model and expressed as standardized mean difference (SMD). Heterogeneity was identified using the Cochran Q test and quantified by the I2 statistic. A total of 8 original cross-sectional studies were included for the quantitative meta-analysis, comprising a total of 13,733 participants from 5 countries. A positive association between adherence to the MedDiet and TL was observed in all meta-analyses, with the exception of those conducted only in men: SMD (95% CI) of 0.130 (0.029; 0.231) for all subjects, 0.078 (0.005; 0.152) for women, and 0.095 (–0.005; 0.195) for men. Only 1 prospective cohort study and 1 RCT were identified, therefore, we could not undertake a meta-analysis for these study designs. The present meta-analysis of cross-sectional studies demonstrates that higher MedDiet adherence is associated with longer TL. At the same time, larger and high-quality prospective studies and clinical trials are warranted to confirm this association.

10 October 2014 in Diabetes Care
Verified
Journal Article
Open access
PDF file
Pablo Hernández-AlonsoPablo Hernández-Alonso
Pablo Hernández-Alonso
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
MBMònica Baldrich-Mora
Mònica Baldrich-Mora
MJMartí Juanola-Falgarona
Martí Juanola-Falgarona
MBMonica Bullo
Monica Bullo
OBJECTIVE: To examine whether a pistachio-rich diet reduces the prediabetes stage and improves its metabolic risk profile. RESEARCH DESIGN AND METHODS: Prediabetic subjects were recruited to participate in this Spanish randomized clinical trial between 20 September 2011 and 4 February 2013. In a crossover manner, 54 subjects consumed two diets, each for 4 months: a pistachio-supplemented diet (PD) and a control diet (CD). A 2-week washout period separated study periods. Diets were isocaloric and matched for protein, fiber, and saturated fatty acids. A total of 55% of the CD calories came from carbohydrates and 30% from fat, whereas for the PD, these percentages were 50 and 35%, respectively (including 57 g/day of pistachios). RESULTS: Fasting glucose, insulin, and HOMA of insulin resistance decreased significantly after the PD compared with the CD. Other cardiometabolic risk markers such as fibrinogen, oxidized LDL, and platelet factor 4 significantly decreased under the PD compared with the CD (P < 0.05), whereas glucagon-like peptide-1 increased. Interleukin-6 mRNA and resistin gene expression decreased by 9 and 6%, respectively, in lymphocytes after the pistachio intervention (P < 0.05, for PD vs. CD). SLC2A4 expression increased by 69% in CD (P = 0.03, for PD vs. CD). Cellular glucose uptake by lymphocytes decreased by 78.78% during the PD (P = 0.01, PD vs. CD). CONCLUSIONS: Chronic pistachio consumption is emerging as a useful nutritional strategy for the prediabetic state. Data suggest that pistachios have a glucose- and insulin-lowering effect, promote a healthier metabolic profile, and reverse certain metabolic deleterious consequences of prediabetes.

4 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
SCSara Castro-Barquero
Sara Castro-Barquero
ATAnna Tresserra-Rimbau
Anna Tresserra-Rimbau
FVFacundo Vitelli-Storelli
Facundo Vitelli-Storelli
MDMònica Domènech
Mònica Domènech
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
Ramon EstruchRamon Estruch
Ramon Estruch
Dietary polyphenol intake is associated with improvement of metabolic disturbances. The aims of the present study are to describe dietary polyphenol intake in a population with metabolic syndrome (MetS) and to examine the association between polyphenol intake and the components of MetS. This cross-sectional analysis involved 6633 men and women included in the PREDIMED (PREvención con DIeta MEDiterranea-Plus) study. The polyphenol content of foods was estimated from the Phenol-Explorer 3.6 database. The mean of total polyphenol intake was 846 ± 318 mg/day. Except for stilbenes, women had higher polyphenol intake than men. Total polyphenol intake was higher in older participants (>70 years of age) compared to their younger counterparts. Participants with body mass index (BMI) >35 kg/m2 reported lower total polyphenol, flavonoid, and stilbene intake than those with lower BMI. Total polyphenol intake was not associated with a better profile concerning MetS components, except for high-density lipoprotein cholesterol (HDL-c), although stilbenes, lignans, and other polyphenols showed an inverse association with blood pressure, fasting plasma glucose, and triglycerides. A direct association with HDL-c was found for all subclasses except lignans and phenolic acids. To conclude, in participants with MetS, higher intake of several polyphenol subclasses was associated with a better profile of MetS components, especially HDL-c.